Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.
Brurberg, Kjetil Gundro, Fønhus, Marita Sporstøl, Larun, Lillebeth et al. · BMJ open · 2014 · DOI
Quick Summary
This study reviewed 20 different definitions doctors use to diagnose ME/CFS and examined 38 research studies that tested how well these definitions work. The researchers found that while one definition (CDC-1994/Fukuda) is used most often, no single definition has been proven to be the best. The study suggests that instead of creating more new definitions, doctors should focus on using the same definitions consistently and grouping patients by symptom patterns to predict who will improve with different treatments.
Why It Matters
Standardized diagnostic criteria are essential for ME/CFS research and clinical care, but conflicting definitions have fragmented the field and made it difficult to compare studies or ensure patients receive consistent diagnoses. This review clarifies that rather than continuing to develop new definitions, the field should adopt consistent standards and use patient subtyping by severity and symptoms to better predict outcomes and treatment responses.
Observed Findings
Twenty distinct case definitions for CFS/ME were identified in the literature.
The CDC-1994/Fukuda definition was the most frequently used across validation studies.
Validation studies were generally small in sample size with significant methodological limitations.
No validation studies adequately assessed reproducibility or practical feasibility of case definitions.
Validation studies produced inconsistent results, making evidence synthesis difficult.
Inferred Conclusions
Creating additional new case definitions for CFS/ME should not be a research priority given the lack of improvement in validity demonstrated by new definitions.
Classifying patients by severity level and symptom pattern may be more clinically useful than developing new case definitions for predicting prognosis and treatment response.
Consistency in research methodology can be achieved by systematically applying and evaluating existing diagnostic criteria rather than proliferating new definitions.
Future efforts should focus on rigorous validation of promising existing criteria rather than creating additional case definitions.
Remaining Questions
Which existing case definition, if any, best captures the biological and clinical reality of ME/CFS and would be most appropriate as a standard for research?
What This Study Does Not Prove
This study does not prove which case definition is 'correct' or most biologically valid, nor does it establish what causes ME/CFS. The review also does not test whether any definition reliably identifies the underlying biological mechanisms of the disease. Additionally, findings about case definition utility cannot be extrapolated to clinical settings where diagnostic practice may differ from research protocols.
How should patients with ME/CFS be subtyped by severity and symptom pattern to create clinically meaningful categories that predict treatment response and prognosis?
What are the specific biological mechanisms or biomarkers that should guide diagnostic criteria development, and how can case definitions be validated against these when no reference standard currently exists?
How can case definitions be redesigned to be more reproducible and feasible for use in both research and clinical practice settings?